The experiments revealed a reduced expression of SRSF1 and SRSF2 in pancreatic, kidney, colorectal, and stomach cancer cell lines as well as in cancer tissues — SRSF2 was downregulated in stomach tumors, while SRSF1 was reduced in all types of tested tumors [39]. This evidence concerns the gene SRSF1 and gastric neoplasm.